Genetics

Latest News

breast cancer
Patients With Breast Cancer and BRCA1, BRCA2, CHEK2, or PALB2 Germline Pathogenic Variants May Benefit From Enhanced Surveillance

January 25th 2023

Patients with breast cancer who carry BRCA1, BRCA2, CHEK2, or PALB2 germline pathogenic variants may be at a greater risk for contralateral breast cancer and may benefit from enhanced surveillance and risk-reduction strategies.

colorectal cancer
Retrospective MOUNTAINEER Analysis Sheds Light on Optimal HER2 Testing Practices in mCRC

January 23rd 2023

Novel Intervention Reduces Time to Molecular Testing for Patients With NSCLC In Community Practice Setting
Novel Intervention Reduces Time to Molecular Testing for Patients With NSCLC In Community Practice Setting

November 7th 2022

Derazantinib Shows PFS Efficacy in FGFR2+ Intrahepatic Cholangiocarcinoma
Derazantinib Shows PFS Efficacy in FGFR2+ Intrahepatic Cholangiocarcinoma

October 8th 2022

Rucaparib Boosts Radiographic Progression-Free Survival in Metastatic Castration-Resistant Prostate Cancer
Rucaparib Boosts Radiographic Progression-Free Survival in Metastatic Castration-Resistant Prostate Cancer

October 7th 2022

Video Interviews

More News

© 2023 MJH Life Sciences

All rights reserved.